Anticonvulsants are drugs used to block seizure initiation and propagation by blocking either abnormal events in a single neuron or the synchronization of related neurons.
The goal of therapy with anticonvulsant drugs is reduction in the firing frequency of neurons.
Only a few of the anticonvulsant drugs available for human use have been approved for clinical use in dogs and cats.
Some of the anticonvulsant drugs are too rapidly metabolized in dogs to be effective, even in high dosages.
Cats metabolize drugs more slowly and poorly than dogs.
The pharmacokinetics of Midazolam in dogs show a shorter elimination half-life of 77 min.
Midazolam can cause changes in behavior in dogs, including irritability, depression, and aberrant demeanor.
Cats may develop acute fatal hepatic necrosis after receiving Midazolam.
In dogs, Midazolam is the drug of choice for the control of emergency status epilepticus and cluster seizures.
Midazolam is more potent than diazepam and is used for status epilepticus, muscle relaxant, tranquilizer, and appetite stimulant the same way as diazepam.
Anticonvulsant drugs act by stabilization of the neuronal membranes evoking hyperpolarization.
Anticonvulsant drugs bind to GABA A receptor and facilitate its action (agonist).
Anticonvulsant drugs inactivate Na+ and Ca+ conductance.
Therapeutic uses of anticonvulsant drugs include reduction of incidence, severity, and duration of seizures.
Adverse effects of anticonvulsant drugs include rapid cessation effect of administration of these drugs and liver and serum enzymes induction.
GABA (Gamma aminobutyric acid) is the major inhibitory NT in the CNS.
GABA is considered our natural “Valium-like” NT.
GABA is produced mostly in the brain from glutamic acid/glutamate and needs Vitamin B6 for its synthesis.
GABA plays an important role in behavior, cognition, and the body response to stress.
Rare adverse effects of Felbamate include generalized tremor and/or keratoconjunctivitis sicca (dry eye) in dogs.
Adverse effects of Felbamate include sedation, ataxia, and anorexia.
There is not enough data for cats.
The cost of Zonisamide can be a problem for dogs.
Zonisamide is particularly useful in cases with brain tumor or cerebral infarct due to its no-sedation effect.
Adverse effects of Zonisamide include sedation, ataxia, and anorexia.
Adverse effects of Felbamate include liver dysfunction in dogs and rare cases of reversible bone marrow depression (condition: thrombocytopenia or leucopenia) in dogs.
Felbamate is administered orally, twice a day.
Felbamate is used as the sole anticonvulsant for patients with local and generalized seizures.
Felbamate is particularly useful in cases with brain tumor or cerebral infarct due to its no-sedation effect.
Felbamate is used as an adjunctive therapy for refractory canine epilepsy and as the sole anticonvulsant for patients with local and generalized seizures.
The mechanism of action of Felbamate is the induction of neural hyperpolarization through inhibition of voltage-dependent Na+ and Ca++ channels.
Felbamate is used as an adjunctive therapy for refractory canine epilepsy less often in cats.
The cost of Felbamate can be a problem for dogs.
Zonisamide is used as an adjunctive therapy for refractory canine epilepsy and as the sole anticonvulsant for patients with local and generalized seizures.
Barbiturates are not useful for terminating an ongoing seizure because the time span from administration until the onset of effect is too long (~ 20 min).
Zonisamide inhibits Na+ and Ca++ channels and induces hyperpolarization.
Unconventional drugs such as Potassium Bromide, Gabapentin, and Levetiracetam inhibit Na+ channels and induce hyperpolarization.
Therapeutic uses of barbiturates include long-term control of seizures and they are administered orally.